192 related articles for article (PubMed ID: 25248287)
21. Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).
AbdelKhalek A; Abutaleb NS; Mohammad H; Seleem MN
PLoS One; 2018; 13(6):e0199710. PubMed ID: 29953486
[TBL] [Abstract][Full Text] [Related]
22. Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria.
Grayson ML; Grabsch EA; Johnson PD; Olden D; Aberline M; Li HY; Hogg G; Abbott M; Kerr PG
Med J Aust; 1999 Aug; 171(3):133-6. PubMed ID: 10474604
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
[TBL] [Abstract][Full Text] [Related]
24. [Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance].
Klare I; Witte W; Wendt C; Werner G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1387-400. PubMed ID: 23114437
[TBL] [Abstract][Full Text] [Related]
25. Control of endemic glycopeptide-resistant enterococci.
Dembry LM; Uzokwe K; Zervos MJ
Infect Control Hosp Epidemiol; 1996 May; 17(5):286-92. PubMed ID: 8727617
[TBL] [Abstract][Full Text] [Related]
26. Correlation between Nosocomial Carriage of Vancomycin-Resistant Enterococci and Antimicrobial Use in Taiwan.
Lee MC; Lu CH; Lee WY; Lee CM
Am J Trop Med Hyg; 2020 Dec; 104(3):1131-1136. PubMed ID: 33319735
[TBL] [Abstract][Full Text] [Related]
27. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
Mueller SW; Kiser TH; Anderson TA; Neumann RT
Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018
[TBL] [Abstract][Full Text] [Related]
28. Vancomycin resistant enterococci healthcare associated infections.
Orsi GB; Ciorba V
Ann Ig; 2013; 25(6):485-92. PubMed ID: 24284534
[TBL] [Abstract][Full Text] [Related]
29. Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme.
Grabsch EA; Mahony AA; Cameron DR; Martin RD; Heland M; Davey P; Petty M; Xie S; Grayson ML
J Hosp Infect; 2012 Dec; 82(4):234-42. PubMed ID: 23103245
[TBL] [Abstract][Full Text] [Related]
30. [Control measures for a VRE outbreak in a haemodialysis unit].
Diguio N; Chanet P; Hautemanière A; Cao-Huu T; Hartemann P; Kessler M
Nephrol Ther; 2009 Jun; 5 Suppl 4():S272-80. PubMed ID: 19596348
[TBL] [Abstract][Full Text] [Related]
31. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.
Lucet JC; Armand-Lefevre L; Laurichesse JJ; Macrez A; Papy E; Ruimy R; Deblangy C; Lozach A; Lolom I; Jarlier V; Andremont A; Leport C
J Hosp Infect; 2007 Sep; 67(1):42-8. PubMed ID: 17719129
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
Flokas ME; Karageorgos SA; Detsis M; Alevizakos M; Mylonakis E
Int J Antimicrob Agents; 2017 May; 49(5):565-572. PubMed ID: 28336313
[TBL] [Abstract][Full Text] [Related]
33. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation.
Nourse C; Murphy H; Byrne C; O'Meara A; Breatnach F; Kaufmann M; Clarke A; Butler K
Eur J Pediatr; 1998 Jan; 157(1):20-7. PubMed ID: 9461358
[TBL] [Abstract][Full Text] [Related]
34. Relapse and reacquisition of rectal colonization by vancomycin-resistant Enterococcus faecium after decolonization.
Lee WG; Park IJ; Jin HY; Park MH
Epidemiol Infect; 2010 Oct; 138(10):1449-53. PubMed ID: 20109265
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature.
Li F; Wang Y; Sun L; Wang X
BMC Infect Dis; 2020 Feb; 20(1):167. PubMed ID: 32087689
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
37. A new use of
Buyukeren M; Yigit S; Buyukcam A; Kara A; Celik HT; Yurdakok M
J Matern Fetal Neonatal Med; 2022 Mar; 35(6):1192-1198. PubMed ID: 32208789
[TBL] [Abstract][Full Text] [Related]
38. Emergence of vancomycin-resistant enterococci.
Rice LB
Emerg Infect Dis; 2001; 7(2):183-7. PubMed ID: 11294702
[TBL] [Abstract][Full Text] [Related]
39. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
[TBL] [Abstract][Full Text] [Related]
40. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
